Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanwei Qingzhi granules for mild hyperlipidemia
ChiCTR-TRC-13003780Phase 2Not yet recruiting
- Sponsor
- Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Sanwei Qingzhi granules in hyperlipidemia (2 arms), sponsored by Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Serum lipid, Bromide ion concentration and 1 more. Planned start Dec 2013; status: not yet recruiting.
02
Drugs
Sanwei Qingzhi granules
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ChiCTR-TRC-13003780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003780.